Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Glucagon-Like Peptide-1 and Its Biological Activity-Reply.

JAMA·2025
Same author

Observations on the Discovery of Glucagon-Like Peptide-1 Action.

JAMA·2025
Same author

Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum.

The European journal of neuroscience·2024
Same author

Circadian organization of lipid landscape is perturbed in type 2 diabetic patients.

Cell reports. Medicine·2023
Same author

The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas.

Endocrine·2023
Same author

A contemporary baseline of Madagascar's coral assemblages: Reefs with high coral diversity, abundance, and function associated with marine protected areas.

PloS one·2022

Related Experiment Video

Updated: Jun 23, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

[Grave's disease in 2009].

Jacques Philippe1

  • 1Service d'endocrinologie, diabétologie et nutrition, HUG, 1211 Genève 14. Jacques.Philippe@hcuge.ch

Revue Medicale Suisse
|May 8, 2009
PubMed
Summary
This summary is machine-generated.

Graves' disease is an autoimmune thyroid disorder causing hyperthyroidism. Treatment involves carbimazole, but recurrence is common, leading to radioactive iodine therapy as a preferred option.

Related Experiment Videos

Last Updated: Jun 23, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

Area of Science:

  • Endocrinology
  • Immunology
  • Thyroidology

Context:

  • Graves' disease affects less than 1% of the population, predominantly women.
  • Characterized by hyperthyroidism, goiter, and potential ophthalmopathy.
  • An autoimmune disorder targeting the thyroid gland.

Purpose:

  • To outline the characteristics and treatment of Graves' disease.
  • To discuss therapeutic strategies for managing hyperthyroidism.
  • To address recurrence rates and alternative treatments.

Summary:

  • Graves' disease is an autoimmune condition leading to hyperthyroidism.
  • Initial treatment involves carbimazole for 12-18 months to inhibit thyroid hormone synthesis.
  • With a 50% recurrence rate post-treatment, radioactive iodine is the recommended therapy for subsequent management.

Impact:

  • Informs clinical decision-making for Graves' disease management.
  • Highlights the high recurrence rate and the role of radioactive iodine.
  • Contributes to understanding autoimmune thyroid disease treatment protocols.